Immunogenic Salmonella typhimurium ribonucleic acid (RNA) preparations, prepared by differential centrifugation, phenol extraction at 65 C, and ethanol precipitation from 0.5% sodium dodecyl sulfate. solution, maintained their immunogenicity through lyophilization. As measured by survival, differential pathogen counts 5 days postchallenge, or clearance of the infecting organism from the tissues, immunization with 50 Ag (dry weight) of the lyophilized preparation proved as effective as immunization with 0.1 LD50 of attenuated S. typhimurium cells. Chromatography of the immunogenic fraction through Biogel P-6 (exclusion limit > 4,600) or through Biogel P-300 (exclusion limit > 300,000) resulted in only one immunogenically active protein of the eluate found in the void volume of the columns. Diethylaminoethyl (DEAE) cellulose anion-exchange chromatography of the RNA preparations showed that the immunogenic activity was eluted from the column at 0.8 to 1.0 M NaCl in a linear 0.1 to 2.0 M NaCl gradient. Nonimmunogenic, protein-containing minor peaks were eluted at 0.1 to 0.5 M NaCl. Serial fractionation of the crude RNA preparations over Biogel P-6 to DEAE cellulose to Biogel P-300 molecular-sieve or anion-exchange columns did not alter the immunogenicity of the RNA preparation. Incorporation of the column fractions into Freund's incomplete adjuvant did not increase their relative effectiveness in eliciting anti-salmonella resistance. Chemical analysis of the immunogenic preparations indicated that they were lacking in detectable protein, lipid, and deoxyribonucleic acid. These results suggest that the immunogenic moiety of the crude nucleic acid fraction is either RNA or an as yet undefined polysaccharide of greater than 300,000 molecular weight. (42) (43) (44) (45) . In more recent work (46), they have further suggested that the immunogenic activity of the fractions may be associated with one particular species of nucleic acid.
Immunogenic Salmonella typhimurium ribonucleic acid (RNA) preparations, prepared by differential centrifugation, phenol extraction at 65 C, and ethanol precipitation from 0.5% sodium dodecyl sulfate. solution, maintained their immunogenicity through lyophilization. As measured by survival, differential pathogen counts 5 days postchallenge, or clearance of the infecting organism from the tissues, immunization with 50 Ag (dry weight) of the lyophilized preparation proved as effective as immunization with 0.1 LD50 of attenuated S. typhimurium cells. Chromatography of the immunogenic fraction through Biogel P-6 (exclusion limit > 4,600) or through Biogel P-300 (exclusion limit > 300,000) resulted in only one immunogenically active protein of the eluate found in the void volume of the columns. Diethylaminoethyl (DEAE) cellulose anion-exchange chromatography of the RNA preparations showed that the immunogenic activity was eluted from the column at 0.8 to 1.0 M NaCl in a linear 0.1 to 2.0 M NaCl gradient. Nonimmunogenic, protein-containing minor peaks were eluted at 0.1 to 0.5 M NaCl. Serial fractionation of the crude RNA preparations over Biogel P-6 to DEAE cellulose to Biogel P-300 molecular-sieve or anion-exchange columns did not alter the immunogenicity of the RNA preparation. Incorporation of the column fractions into Freund's incomplete adjuvant did not increase their relative effectiveness in eliciting anti-salmonella resistance. Chemical analysis of the immunogenic preparations indicated that they were lacking in detectable protein, lipid, and deoxyribonucleic acid. These results suggest that the immunogenic moiety of the crude nucleic acid fraction is either RNA or an as yet undefined polysaccharide of greater than 300,000 molecular weight.
Within the past 5 (42) (43) (44) (45) . In more recent work (46) , they have further suggested that the immunogenic activity of the fractions may be associated with one particular species of nucleic acid. 1 Preliminary results of this investigation were presented at the Annual Meeting of the American Society for Microbiology, Minneapolis, Minn., 2-7 May 1971. Immunization with bacterial ribosomal preparations has also been found to be an effective means of prophylaxis for infections with Staphylococcus aureus (41) , Pseudomonas aeruginosa (40) , Diplococcus pneumoniae (30) , and Salmonella typhimurium (35) . The immunogenic fractions of these organisms consist of approximately 60% RNA, 30% protein, and 10%7, "contaminant" material on a dry weight basis. The active moiety in these preparations, however, has not been defined.
In recent work from this laboratory, evidence was presented to indicate that immunization with phenol-extracted RNA preparations obtained from S. typhimurium protects mice against subsequent challenge with virulent bacilli (36) . In view of the heterogeneous chemical composi-tion reported for the immunogenic preparations [97% RNA, < 0.5% protein, < 0.02% deoxyribonucleic acid (DNA), and approximately 2% miscellaneous carbohydrate], the identity of the active moiety in these fractions has remained obscure. This communication details results obtained through purifying the immunogenic RNA preparations by molecular-sieve and anionexchange chromatography. The data strongly suggest that the active moiety is associated with a substance(s) of a molecular weight greater than 300,000.
MATERIALS AND METHODS Organism. S. typhimurium strains SR-11 and RIA were employed throughout this investigation. The LDso values of these strains for mice were less than 10 and approximately 5 X 104 bacteria per animal, respectively (36 The homogenate was subjected to two preliminary centrifugations at 27,000 and 45,000 X g in a Sorvall RC-2B refrigerated centrifuge. After the 45,000 X g centrifugation, the supernatant fluid was centrifuged at 105,000 X g for 3 hr in a Beckman model L refrigerated ultracentrifuge. The pellet from this centrifugation was suspended to a concentration of 50 mg (moist weight) per ml in 0.01 M phosphate buffer, pH 7.19, at 25 C, and was incubated with 5 ,ug of deoxyribonuclease per ml for 30 min at 15 C.
After incubation, one volume of hot (65 C), buffersaturated phenol (suspended in and equilibrated three times with 0.01 M phosphate buffer, pH 7.19, at 25 C, containing 0.5% SDS) was added to this suspension, and the mixture was agitated vigorously for 10 min at 65 C. The aqueous phase was separated from the phenol phase by centrifugation for S min at 2,100 rev/min in an International HN-S centrifuge, and was decanted (the phenol phase was discarded). Extraction of the aqueous phase with 1 volume of hot buffersaturated phenol was repeated at least four times or until the aqueous-phenol interphase was free from denatured protein. Subsequent to the final centrifugaion, the upper two-thirds of the aqueous phase was carefully decanted and brought to 0.1 M NaCl by the addition of 1 M NaCl in 0.01 M phosphate buffer. Two volumes (v/v) of cold (-20 C) absolute ethanol were added to the preparation, and the mixture was permitted to stand overnight at -20 C.
The following day, the nucleic acid precipitate was collected by centrifugation at 10,000 X g for 5 min in a Sorvall refrigerated centrifuge (model-RC-2B), and was suspended in 0.01 M phosphate buffer, pH 7.1, at 25 C, containing 0.1 M NaCl. Two volumes (v/v) of absolute ethanol were again added, and the mixture was stored at -20 C for 4 hr. After collecting the precipitate and resuspending the pellet in 50 ml of 0.01 M phosphate buffer containing 0.1 M NaCl, an equal volume of 1.0% SDS (in 0.01 M phosphate buffer, pH 7.19, at 25 C, containing 0.1 M NaCl) was added, and the mixture was incubated for 30 min at 25 C under moderate agitation. The nucleic acid was then precipitated out of solution by the addition of 2 volumes of cold absolute ethanol. This mixture was stored at -20 C for 4 hr, collected by centrifugation at 10,000 X g as described above, and suspended in 50 ml of phosphate-NaCl buffer. The precipitation and collection of the nucleic acid were repeated an additional four times. The final pellet was then suspended in either sterile, pyrogen-free isotonic saline or 0.01 M phosphate-NaCl buffer, and was lyophilized immediately.
The yield of the nucleic acid fraction obtained by this procedure was approximately 0.2 to 0.4% of the moist weight of the cell mass. Qualitatively, the fraction exhibited an adsorption spectrum between 210 and 310 nm, which is comparable to that reported for nucleic acids (14, 25) , and an A26o/mg equal to 20. (36) .
Molecular-sieve chromatography. Biogel P-6 (molecular weight exclusion limit > 4,600) and Biogel P-300 (molecular weight exclusion > 300,000) were obtained from BioRad Laboratories, Richmond, Calif. The appropriate columns were charged with 50 mg of the crude RNA preparation suspended in 5 ml of 0.01 M phosphate buffer, pH 7.19, at 25 C, containing 0.1 M NaCl. A Biogel P-6 column 50 by 1.5 cm was eluted at a flow rate of 60 ml per hr with the suspending phosphate-NaCl buffer. A Biogel P-300 column 30 by 2.5 cm was similarly eluted at a flow rate of 8 ml per hr. The eluates of the columns were monitored through an Isco dual-beam ultraviolet analyzer and recorder (model UA-2) at OD254, and fractions were collected in 2-and 5-ml quantities from the P-6 and P-300 col- (27) .
(ii) Differential pathogen counts at 5 days postchallenge (4): Challenged animals were individually killed by cervical dislocation; the animals were skinned, their feet and tails were removed, and the gastrointestinal tract was excised. The weight of the carcass was determined, and sterilized distilled water was added to yield a total volume of 100 ml. The suspension was homogenized for 3 min in a Waring
Blendor, and 10-fold serial dilutions of the homogenate were prepared in sterile, isotonic saline and plated in 0.1-ml quantities on SS Agar (Difco). After incubation at 37 C for 24 hr, the number of viable bacteria in each dilution was determined, and the number of bacteria in the original homogenate was calculated. The number of bacteria per gram of tissue for each animal was determined as described elsewhere (33) . Statistical significance of differences between values obtained for the treated and untreated groups were determined by rank order evaluation (39) .
(iii) Pathogen tissue clearance: At 2, 4, 7, 10, 15, and 30 days postchallenge, the number of bacteria per gram of tissue for infected normal and treated mice was determined as defined above. The data are presented as the mean number of bacteria per gram of tissue versus the time postchallenge at which the animals were sacrificed.
Chemical analyses. Protein was determined by the Lowry technique (20) with bovine serum albumin (Nutritional Biochemicals Corp.) as the standard. These results were confirmed by polyacrylamide disc electrophoresis on 2 mg (dry weight) of the fractions in 5% gels by the procedure of Maurer (21) . DNA and RNA were defined by the diphenylamine (11) and orcinol tests (25) , respectively. Sperm DNA and purified yeast soluble RNA obtained from Nutritional Biochemicals Corp. were employed as standards. Lipid was qualitatively determined by thin-layer chromatography as described previously (36) . Total carbohydrate concentrations were assayed by the phenol-sulfuric acid method of Dubois et al. (12), with D-ribose (Nutritional Biochemicals Corp.) as the standard.
RESULTS
Vaccine standardization. One limitation anticipated in attempts to purify the active moiety in the crude S. typhimuriwn RNA preparations was the previously reported temperature lability of the activity upon storage of the fraction at either 4 or -20 C (36). Because of the use of the modified extraction procedure employed in this study, and the immediate lyophilization of the crude fraction, the immunogenicity of the preparations in the lyophilized state required definition. Accordingly, mice were immunized with 50 Ag (dry weight) of the RNA that had been stored in this manner for 1, 2, or 3 months. Animals immunized with 0.1 LD50 of attenuated S. typhimurium strain RIA or with 50 Mig (dry weight) of the freshly prepared RNA served as positive controls. After 15 days, all animals were challenged with 65 LD50 of virulent S. typhimurium SR-11. As measured by survival (Table 1) , the immunogenicity of the lyophilized RNA preparations was comparable to that observed in the animals immunized with either the freshly prepared RNA or the attenuated salmonellae. There was no definable correlation between a loss in immunogenicity and the time of storage for the immunogenic RNA preparations. Similarly, there was no significant decrease in the efficacy of the lyophilized fractions as measured by the more sensitive (15) differential pathogen count immune assay ( Fig. 1) .
One criticism of the use of the preceding immune assays in determining the efficacy of a vaccine preparation is the inability of either survival or differential pathogen counts to detect 271 VOL. 5 To examine the immunogenicity of the column eluate, fractions were pooled as shown in Fig. 3 and lyophilized; then 50 ,ug (dry weight) was injected into 60 mice. In each group, 30 mice received the fractions incorporated into Freund's incomplete adjuvant, 30 received the preparation in saline. At 15 days postimmunization, the animals injected with the preparations suspended in saline were challenged with 62 LD50 of S. typhimurium SR-11. At 30 days postimmunization, the mice that received the fractions incorporated into adjuvant were similarly infected. Unimmunized animals served as normal controls. The results from these experiments are presented in Table 2 and Fig. 4 . As measured by either survival or the ability of the immunized animal to inhibit or retard bacterial multiplication, the only portion of the eluate found to be immunogenic was that portion containing the RNA located in the void volume of the column. Adjuvant did little to increase the efficacy of any of the fractions in inducing resistance to the challenge infection.
Molecular-sieve chromatography, Biogel P-300. Subsequent elution of the immunogenic RNA preparations through Biogel-300 (molecular weight exclusion limit > 300,000) with 0.01 M the differential pathogen counts at 5 days postchallenge are presented in Table 3 and Fig. 6 , respectively. The only mice found to be both resistant to the challenge and capable of inhibiting the multiplication of the organism were those Table  4) . Regardless of the incorporation of the fractions into adjuvant, the only pooled eluate found to be immunogenic was that containing the RNA of the bacteria.
Serial column purification. Although purification of the immunogenic RNA preparations through elution of the fraction over Biogel P-6, Biogel P-300, or DEAE cellulose had indicated that the immunogenicity of the subcellular fraction was associated with the nucleic acid in the preparation, the ability of a serially purified nucleic acid fraction to induce substantive antisalmonella resistance had not been examined. Consequently, when the crude sample was employed as the column charge, it was possible that a contaminant of the initial preparation was continually carried throughout the fractionation into the immunogenic eluate. To exclude this possibility, the nucleic acid peak obtained off the Biogel P-6 (cf. Fig. 3, peak I ) was applied to a DEAE cellulose column and eluted with a linear 0.1 to 2.0 M NaCl gradient in 0.01 M phosphate buffer, pH 7.19, at 25 C. The fractions representing the major portion of the nucleic acid peak obtained from anion-exchange chromatography * :
on October 28, 2017 by guest http://iai.asm.org/ Downloaded from (cf. Fig. 9 , peak III) were pooled and eluted through Biogel P-300. The fractions of the P-300 eluent containing the nucleic acid were pooled (cf. ,ug dry weight ofthe non-OD2M-absorbing portion of the Biogel P-300 column, respectively. Each dot represents the value obtained,from one animal; the bracketed lines define the mneami i the standard error. cutaneously in saline into normal mice (50 ,g, dry weight, per animal). Unimmunized animals and mice immunized with 50 ,ug (dry weight) of the crude RNA, 0.1 LD0 of attenuated S. typhimurium strain RIA, or 50 ,ug of the pooled and lyophilized non-nucleic acid-containing fractions of the P-300 column (cf. Fig. 5, peak II) served as controls. At 15 days postimmunization, the animals were challenged with 52 LD50 of virulent S. typhimurium SR-Il. As measured by the ability of the immunized animals to inhibit or retard bacterial multiplication 5 days postchallenge (Fig.  11) , fraction I was the only portion of the P-300 eluent that induced a resistance comparable to that induced with the crude RNA and attenuated salmonella vaccine preparations. The non-nucleic acid-containing protein of the gradient (fraction II) did not elicit substantive resistance. Similarly, immunization with fraction I resulted in elimination of the pathogen from the tissue (Fig. 12) , whereas the normal controls and animals immunized with 50 Mug of fraction II supported the growth of the challenge inocula and had succumbed to infection within 15 days postchallenge.
Chemical assay. Chemical tests were conducted on 50-mg (dry weight) samples of the various immunogenic column eluates. Six samples of Biogel P-6 fraction I, five samples of DEAE cellulose fraction III, three samples of Biogel P-300 fraction I, and four samples of the serial purification void volume were tested. Protein was present (<0.008%o) only in fraction I of the Biogel P-6 eluates by the (11, 20, 25, 27) 
DISCUSSION
In previous reports from this laboratory, immunization with hot phenol-SDS extracted RNA preparations of S. typhimuriwn has been shown to be an effective means of inducing immunity to experimental salmonellosis of the mouse (32) (33) (34) 36) . The data presented in this investigation fully support the contention that these subcellular extracts elicit a true protective immune response as defined by Collins (7) (8) (9) . Mice immunized with 50 Mg (dry weight) of the phenol-extracted RNA were able to resist subsequent infection by the homologous pathogen. The resistance was exemplified by the ability of the challenge animals both to survive the infection and to suppress the growth of the bacteria at 5 days postchallenge. The In additional support of this thesis, earlier work from this laboratory demdnstrated that the major contaminant of the fraction was nonribose carbohydrate (36) . It is important to note, however, that small-molecular-weight (<4,600) nonpolar material was removed from the crude preparations via molecularsieve chromatography over Biogel P-6. Although this would appear to diminish the probability that carbohydrate was involved, it does not exclude the possibility that a charged derivative was absorbed to the highly polar nucleic acid eluted in the void volume of the column. In addition, regardless of ionic charge, if the molecular weight of the carbohydrate was greater than 4,600 it would not be separable from the RNA through this means. It should be stated, however, that via the Biogel P-300 molecular sieve and serial purification scheme, polar material and residues of less than 300,000 molecular weight should have been differentially eluted from the nucleic acid. Similarly, chemical analysis of the serially purified RNA suggests that the total carbohydrate of the preparation can be accounted for by the pentose concentration empirically determined for the RNA of the fraction (approximately 25% on a dry weight basis). These data strongly indicate that a carbohydrate contaminant is not responsible for the activity of the fraction. Along similar lines, the possibility that a protein or RNA-absorbed peptide fragment is responsible for the immunogenicity of the RNA must be considered, since the crude fractions are known to contain from 1.0 to 0.1% of the cellular protein. Protein, however, was separated from the nucleic acid through anion-exchange chromatography. In addition, the proteins eluted from the preparation were not immunogenic, regardless of whether they were or were not incorporated into adjuvant. Similarly, through the quantitation of protein in the sample via polyacrylamide disc electrophoresis and colorimetric assay, it was demonstrated that, if present, proteinaceous material accounted for less than 0.001 % of the immunogenic preparation. Assuming that the percentage stands up under more rigorous analytical tests, these data in effect would require that a unique peptide must be active in less than 0.0005 Mg per 50-,ug (dry weight) immunizing dose. Although this is feasible, the degree of resistance ob-VOL. 5, 1972 served subsequent to immunization, coupled with the necessity of converting an entire animal to an immune state, renders this possibility unlikely.
The possibility that a contaminant molecular species is responsible for the immunogenicity of the fraction would be further limited if one were to consider the comparative efficacy of immunizing with equivalent quantities of the crude and purified RNA preparations. Immunization with 50 ,ug (dry weight) of the purified fraction elicited an immune state comparable to that obtained with 50 j,g of the crude RNA. In conjunction with this equal immunizing potency, it is interesting to note that the concentration of contaminant material in the fractions was reduced from approximately 3 %7 to less than 0.003%, of the dry weight of the preparation. Whereas there existed an approximate 1,000-fold decrease in non-nucleic acid material, a commensurate decrease in the immunizing potency of the fraction was not observed. This fact alone would strongly indicate that a contaminant molecule acting independently of the nucleic acid is not responsible for the activity of the fraction.
The second possible general explanation for the immunogenicity of both the crude and purified subcellular preparations is that a molecule in close association with the RNA of the preparation is responsible for the observed anti-salmonella resistance. This in effect would be attributing to the RNA the function of acting in an adjuvant-like manner, and as such would be in support of the work of several other laboratories (15, 19, 22 It is possible that a bactericidal effect mediated by antiviral interferon could be responsible for the observed response. It is well documented that gram-negative bacterial preparations and subcellular fractions can and do induce the production of interferon in immunized animals (1, 28, 29) . Foreign nucleic acids are also documented to act in a comparable fashion (13, 23) . Similarly, the antibacterial-antifungal effect of interferon or interferon-like substances has received recent support from several laboratories (23, 24, 28) . These data suggest that one response to be anticipated in animals immunized with salmonella RNA would be the production of interferon. It is important to note, however, that the degree of resistance induced with the salmonella fractions cannot be explained on the basis of a low-level resistance characteristic of the interferon-mediated bactericidal response (28) . Similarly, endotoxin and synthetic polynucleotides are known to be effective inducers of interferon production (23, 24, 28) . These substances, however, do not elicit a response comparable to that induced with the immunogenic RNA preparations (35, 36, 47 ; unpublished data). By this reasoning, therefore, it would seem improbable that nucleic acid-induced interferon is responsible for the RNA-elicited anti-salmonella response.
As a final alternative mechanism, it should be considered that the bacterial RNA 
